Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124702252 | 12470225 | 2 | F | 2016 | 20160808 | 20160616 | 20160812 | EXP | GB-AMGEN-GBRSP2016053634 | AMGEN | 65.00 | YR | E | M | Y | 0.00000 | 20160812 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124702252 | 12470225 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNK | U | 125031 | 6 | MG | UNKNOWN FORMULATION | ||||||
| 124702252 | 12470225 | 2 | C | FLUCLOXACILLIN | FLUCLOXACILLIN | 1 | UNK | 0 | |||||||||||
| 124702252 | 12470225 | 3 | C | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 124702252 | 12470225 | 4 | C | PALONOSETRON | PALONOSETRON | 1 | Intravenous (not otherwise specified) | 250 MCG, UNK | 0 | ||||||||||
| 124702252 | 12470225 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 124702252 | 12470225 | 6 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | UNK | 0 | |||||||||||
| 124702252 | 12470225 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | 0 | |||||||||||
| 124702252 | 12470225 | 8 | C | LOPERAMIDE | LOPERAMIDE | 1 | UNK | 0 | |||||||||||
| 124702252 | 12470225 | 9 | C | DOMPERIDONE | DOMPERIDONE | 1 | UNK | 0 | |||||||||||
| 124702252 | 12470225 | 10 | C | CISPLATIN. | CISPLATIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124702252 | 12470225 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124702252 | 12470225 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124702252 | 12470225 | Arthralgia | |
| 124702252 | 12470225 | Asthenia | |
| 124702252 | 12470225 | Constipation | |
| 124702252 | 12470225 | Dysgeusia | |
| 124702252 | 12470225 | Fatigue | |
| 124702252 | 12470225 | Injection site haemorrhage | |
| 124702252 | 12470225 | Joint swelling | |
| 124702252 | 12470225 | Neoplasm | |
| 124702252 | 12470225 | Pain in extremity | |
| 124702252 | 12470225 | Pulmonary embolism | |
| 124702252 | 12470225 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124702252 | 12470225 | 1 | 20160330 | 0 |